Embedded Files
Our Core Leadership
Mohan Purushothaman
Mohan is an entrepreneur with a strong track record in the life sciences industry. He has several years of experience in the Pharma industry followed by more than two decades of work as a strategic advisor to various pharma companies world-wide.
James Wilcox
Jim has nearly 40 years’ experience in the biopharma, biotechnology, diagnostics, and life sciences. He has served over 25 years as a senior executive and corporate board member and has diverse experience as senior legal counsel in all aspects of corporate law
Gerald Lushington
With over 25 years experience in pharmacology, biology and chemistry research. Cited more than 5000 times, Gerry has 5 full patents and 230+ publications on AI, simulations, pharmaceutics, chemistry, toxicology, pathology and physiology
Erika Geimonen
Over 20 years of experience in business development and research, Erika brings deep expertise in licensing, product management, acquisitions, operations and strategic planning, plus demonstrated success in negotiating Pharma and Biotech deals and M&As,
Neil Kelleher
Walter and Mary Elizabeth Glass Prof of Molecular Biosciences,
Prof of Chemistry, Director, Chemistry of Life Processes Institute.
Director of the 50-person Proteomics Center of Excellence and a member of the Robert H. Lurie Comprehensive Cancer Center of NW University. His Research focused in the areas of top-down proteomics, natural products discovery, and cancer biology.
Francis Barany
National Academy of Inventors Fellow.
Professor of Microbiology, Weill Cornell Medicine.
Inventor of the LCR, LDR and Universal DNA arrays - foundation for tests to diagnose genetic diseases, detect pathogens, identify cancer mutations, and identify diseases using DNA microarrays.
Elaine Hamm
Elaine is the CEO of the pharmaceutical accelerator, Ascend BioVentures.
Prior to joining Ascend BioVentures, Dr. Hamm was the COO of Accele BioPharma and served as management for a portfolio of early stage pharmaceutical companies ranging from diabetes to hearing loss to infectious disease.
Ray Mernaugh
Brings over forty years of academic and industrial experience in the production, detection, characterization and use of polyclonal, hybridoma monoclonal and recombinant antibodies and immuno-conjugates for research, diagnostic and therapeutic applications.
Sergei Brodsky
Professor, Department of Pathology, The Ohio State University Wexner Medical Center (OSUWMC) where he shares his time between clinics and research. He brings more than twenty-five years practice in medical field and research and his primary research and medical interests are in the areas of vascular biology and renal pathophysiology.
Page updated
Report abuse